Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function
Iris E. Beldhuis, Peder L. Myhre, Michael R. Bristow, Brian Claggett, Kevin Damman, James C. Fang, Jerome L. Fleg, Sonja M. McKinlay, Eldrin F. Lewis, Eileen O’Meara, Bertram Pitt, Sanjiv J. Shah, Orly Vardeny, Adriaan A. Voors, Marc A. Pfeffer, Scott D. Solomon, Akshay S. Desai
Topics & Concepts
MedicineSpironolactoneHeart failureHazard ratioInternal medicineCardiologyClinical endpointEjection fractionConfidence intervalOdds ratioPlaceboHeart failure with preserved ejection fractionRenal functionProportional hazards modelRandomized controlled trialAlternative medicinePathologyHormonal Regulation and HypertensionHeart Failure Treatment and ManagementTakotsubo Cardiomyopathy and Associated Phenomena